News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mack David Henry
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/08/2023 |
4
| Mack David Henry (President and CEO) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Exercised 85,500 options to buy
@ $0.53, valued at
$45.3k
|
|
| 05/15/2023 |
4
| Mack David Henry (President and CEO) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 330,000 options to buy
@ $5.7, valued at
$1.9M
|
|
| 04/29/2022 |
4
| Mack David Henry (President and CEO) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Exercised 33,000 options to buy
@ $0.53, valued at
$17.5k
|
|
| 03/09/2022 |
4
| Mack David Henry (President and CEO) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Gifted 40,000 shares
@ $0
Gifted 40,000 shares
@ $0
Exercised 20,000 options to buy
@ $1.37, valued at
$27.4k
|
|
| 02/28/2022 |
4
| Mack David Henry (President and CEO) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 249,600 options to buy
@ $16.29, valued at
$4.1M
|
|
| 12/16/2021 |
4
| Mack David Henry (President and CEO) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Gifted 40,000 shares
@ $0
Gifted 40,000 shares
@ $0
Exercised 9,000 options to buy
@ $0.53, valued at
$4.8k
|
|
| 08/20/2021 |
4
| Mack David Henry (President and CEO) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Exercised 5,500 options to buy
@ $0.53, valued at
$2.9k
|
|
| 07/22/2021 |
4
| Mack David Henry (President and CEO) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Sold 1,029 shares
@ $35.53, valued at
$36.6k
Sold 26,767 shares
@ $35.7564, valued at
$957.1k
Exercised 1,029 options to buy
@ $0.53, valued at
$545.4
Exercised 26,767 options to buy
@ $0.53, valued at
$14.2k
|
|
| 06/29/2021 |
4
| Mack David Henry (President and CEO) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Sold 204 shares
@ $35.53, valued at
$7.2k
Exercised 204 options to buy
@ $0.53, valued at
$108.1 |
|
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/20/2020 |
4
| Mack David Henry (President and CEO) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Exercised 2,470 options to buy
@ $0.53, valued at
$1.3k
|
|
| 09/24/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/28/2020 |
4
| Mack David Henry (Director) has filed a Form 4 on ADURO BIOTECH, INC.|
Txns:
| Granted 30,000 options to buy
@ $3, valued at
$90k
|
|
| 05/15/2019 |
4
| Mack David Henry (Director) has filed a Form 4 on ADURO BIOTECH, INC.|
Txns:
| Granted 30,000 options to buy
@ $3.29, valued at
$98.7k
|
|
| 02/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/25/2013 |
3
| Mack David Henry (Director) has filed a Form 3 on AERIE PHARMACEUTICALS INC |
| 02/18/2011 |
4
| ACP IV, L.P. (10% Owner) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Converted 682,904 shares
@ $0
Converted 328,064 shares
@ $0
Converted 810,129 shares
@ $0
Converted 279,097 shares
@ $0
Converted 14,713 shares
@ $0
Bought 680,000 shares
@ $5, valued at
$3.4M
Converted 500,000 options to buy
@ $0
Converted 218,750 convertible preferred
@ $0
Converted 810,129 convertible preferred
@ $0
Disposed of convertible notes
@ $0
Disposed of 40,865 options to buy
@ $0 |
|
| 02/10/2011 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|